|
1
|
Levine B and Kroemer G: Autophagy in the
pathogenesis of disease. Cell. 132:27–42. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cinque L, Forrester A, Bartolomeo R,
Svelto M, Venditti R, Montefusco S, Polishchuk E, Nusco E, Rossi A,
Medina DL, et al: FGF signalling regulates bone growth through
autophagy. Nature. 528:272–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sasaki H, Takayama K, Matsushita T, Ishida
K, Kubo S, Matsumoto T, Fujita N, Oka S, Kurosaka M and Kuroda R:
Autophagy modulates osteoarthritis-related gene expression in human
chondrocytes. Arthritis Rheum. 64:1920–1928. 2012. View Article : Google Scholar
|
|
4
|
Zhao H, Zhang T, Xia C, Shi L, Wang S,
Zheng X, Hu T and Zhang B: Berberine ameliorates cartilage
degeneration in interleukin-1β-stimulated rat chondrocytes and in a
rat model of osteoarthritis via Akt signalling. J Cell Mol Med.
18:283–292. 2014. View Article : Google Scholar
|
|
5
|
Cheng L, Zeng G, Liu Z, Zhang B, Cui X,
Zhao H, Zheng X, Song G, Kang J and Xia C: Protein kinase B and
extracellular signal-regulated kinase contribute to the
chondroprotective effect of morroniside on osteoarthritis
chondrocytes. J Cell Mol Med. 19:1877–1886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou PH, Liu SQ and Peng H: The effect of
hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat
model of osteoarthritis. J Orthop Res. 26:1643–1648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ribeiro M, López de Figueroa P,
Nogueira-Recalde U, Centeno A, Mendes AF, Blanco FJ and Caramés B:
Diabetes-accelerated experimental osteoarthritis is prevented by
autophagy activation. Osteoarthritis Cartilage. 24:2116–2125. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Vasheghani F, Li YH, Blati M,
Simeone K, Fahmi H, Lussier B, Roughley P, Lagares D, Pelletier JP,
et al: Cartilage-specific deletion of mTOR upregulates autophagy
and protects mice from osteoarthritis. Ann Rheum Dis. 74:1432–1440.
2015. View Article : Google Scholar
|
|
9
|
Cui X, Wang S, Cai H, Lin Y, Zheng X,
Zhang B and Xia C: Overexpression of microRNA-634 suppresses
survival and matrix synthesis of human osteoarthritis chondrocytes
by targeting PIK3R1. Sci Rep. 6:231172016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen J, Crawford R and Xiao Y: Vertical
inhibition of the PI3K/Akt/mTOR pathway for the treatment of
osteoarthritis. J Cell Biochem. 114:245–249. 2013. View Article : Google Scholar
|
|
11
|
Baltzer AW, Moser C, Jansen SA and Krauspe
R: Autologous conditioned serum (Orthokine) is an effective
treatment for knee osteoarthritis. Osteoarthritis Cartilage.
17:152–160. 2009. View Article : Google Scholar
|
|
12
|
Moser C: Response to: cytokine profile of
autologous conditioned serum for treatment of osteoarthritis, in
vitro effects on cartilage metabolism and intra-articular levels
after injection. Arthritis Res Ther. 12:4102010. View Article : Google Scholar
|
|
13
|
Rutgers M, Saris DB, Dhert WJ and Creemers
LB: Cytokine profile of autologous conditioned serum for treatment
of osteoarthritis, in vitro effects on cartilage metabolism and
intra-articular levels after injection. Arthritis Res Ther.
12:R1142010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Attur MG, Dave M, Cipolletta C, Kang P,
Goldring MB, Patel IR, Abramson SB and Amin AR: Reversal of
autocrine and paracrine effects of interleukin 1 (IL-1) in human
arthritis by type II IL-1 decoy receptor. Potential for
pharmacological intervention. J Biol Chem. 275:40307–40315. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng G, Cui X, Liu Z, Zhao H, Zheng X,
Zhang B and Xia C: Disruption of phosphoinositide-specific
phospholipases Cγ1 contributes to extracellular matrix synthesis of
human osteoarthritis chondrocytes. Int J Mol Sci. 15:13236–13246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li C, Cai S, Wang X and Jiang Z:
Identification and characterization of ANO9 in stage II and III
colorectal carcinoma. Oncotarget. 6:29324–29334. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zheng CH and Levenston ME: Fact versus
artifact: Avoiding erroneous estimates of sulfated
glycosaminoglycan content using the dimethylmethylene blue
colorimetric assay for tissue-engineered constructs. Eur Cell
Mater. 29:224–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang B and Xia C:
12-O-tetradecanoylphorbol-1, 3-acetate induces the negative
regulation of protein kinase B by protein kinase Calpha during
gastric cancer cell apoptosis. Cell Mol Biol Lett. 15:377–394.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shao XX, Duncan NA, Lin L, Fu X, Zhang JY
and Yu CL: Serum-free media for articular chondrocytes in vitro
expansion. Chin Med J (Engl). 126:2523–2529. 2013.
|
|
20
|
Wolf F, Haug M, Farhadi J, Candrian C,
Martin I and Barbero A: A low percentage of autologous serum can
replace bovine serum to engineer human nasal cartilage. Eur Cell
Mater. 15:1–10. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jain MV, Paczulla AM, Klonisch T, Dimgba
FN, Rao SB, Roberg K, Schweizer F, Lengerke C, Davoodpour P,
Palicharla VR, et al: Interconnections between apoptotic,
autophagic and necrotic pathways: Implications for cancer therapy
development. J Cell Mol Med. 17:12–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laplante M and Sabatini DM: mTOR signaling
in growth control and disease. Cell. 149:274–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Inoki K, Li Y, Xu T and Guan KL: Rheb
GTPase is a direct target of TSC2 GAP activity and regulates mTOR
signaling. Genes Dev. 17:1829–1834. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tee AR, Manning BD, Roux PP, Cantley LC
and Blenis J: Tuberous sclerosis complex gene products, Tuberin and
Hamartin, control mTOR signaling by acting as a GTPase-activating
protein complex toward Rheb. Curr Biol. 13:1259–1268. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bohensky J, Leshinsky S, Srinivas V and
Shapiro IM: Chondrocyte autophagy is stimulated by HIF-1 dependent
AMPK activation and mTOR suppression. Pediatr Nephrol. 25:633–642.
2010. View Article : Google Scholar :
|
|
26
|
Xue JF, Shi ZM, Zou J and Li XL:
Inhibition of PI3K/AKT/mTOR signaling pathway promotes autophagy of
articular chondrocytes and attenuates inflammatory response in rats
with osteoarthritis. Biomed Pharmacother. 89:1252–1261. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takayama K, Kawakami Y, Kobayashi M, Greco
N, Cummins JH, Matsushita T, Kuroda R, Kurosaka M, Fu FH and Huard
J: Local intra-articular injection of rapamycin delays articular
cartilage degeneration in a murine model of osteoarthritis.
Arthritis Res Ther. 16:4822014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosa SC, Rufino AT, Judas F, Tenreiro C,
Lopes MC and Mendes AF: Expression and function of the insulin
receptor in normal and osteoarthritic human chondrocytes:
Modulation of anabolic gene expression, glucose transport and
GLUT-1 content by insulin. Osteoarthritis Cartilage. 19:719–727.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cravero JD, Carlson CS, Im HJ, Yammani RR,
Long D and Loeser RF: Increased expression of the Akt/PKB inhibitor
TRB3 in osteoarthritic chondrocytes inhibits insulin-like growth
factor 1-mediated cell survival and proteoglycan synthesis.
Arthritis Rheum. 60:492–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hahn-Windgassen A, Nogueira V, Chen CC,
Skeen JE, Sonenberg N and Hay N: Akt activates the mammalian target
of rapamycin by regulating cellular ATP level and AMPK activity. J
Biol Chem. 280:32081–32089. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peng M, Huang Y, Tao T, Peng CY, Su Q, Xu
W, Darko KO, Tao X and Yang X: Metformin and gefitinib cooperate to
inhibit bladder cancer growth via both AMPK and EGFR pathways
joining at Akt and Erk. Sci Rep. 6:286112016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Galasso O, Panza S, Santoro M, Goldring
MB, Aquila S and Gasparini G: PTEN elevation, autophagy and
metabolisc reprogramming may be induced in human chondrocytes
during steroids or nutrient depletion and osteoarthritis. J Biol
Regul Homeost Agents. 29(Suppl 4): S1–S14. 2015.
|
|
33
|
Memmott RM and Dennis PA: Akt-dependent
and -independent mechanisms of mTOR regulation in cancer. Cell
Signal. 21:656–664. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
O'Reilly KE, Rojo F, She QB, Solit D,
Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, et al:
mTOR inhibition induces upstream receptor tyrosine kinase signaling
and activates Akt. Cancer Res. 66:1500–1508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yori JL, Lozada KL, Seachrist DD, Mosley
JD, Abdul-Karim FW, Booth CN, Flask CA and Keri RA: Combined
SFK/mTOR inhibition prevents rapamycin-induced feedback activation
of AKT and elicits efficient tumor regression. Cancer Res.
74:4762–4771. 2014. View Article : Google Scholar : PubMed/NCBI
|
